Metabolism &
Cellular Bioenergetics
Cellular metabolism responds to nutrients, hormones and cofactors. Transcriptomics reads the genes encoding the enzymes of ATP production and substrate selection, at the point where they are switched on: transcription.
Quantifying Energy Homeostasis
Traditional blood panels measure circulating metabolites and proteins. Transcriptomics measures the gene transcription upstream of them. The two describe different layers of the same biology.
Bioenergetic transcriptomics measures the transcription of enzymes directly involved in cellular respiration. By tracking shifts in genes regulating glycolysis, fatty acid oxidation, and the oxidative phosphorylation (OXPHOS) machinery, we gain a direct window into how efficiently cells convert nutrients into ATP.
Key Pathway Targets
AMP-Activated Protein Kinase (AMPK)
Master regulator of energy homeostasis; promotes ATP-producing catabolic pathways.
PGC-1α
Coordinates mitochondrial biogenesis and transition to oxidative metabolism.
NADH:Ubiquinone Oxidoreductase Core Subunit S1
Crucial component of Complex I in the electron transport chain (OXPHOS).
Succinate Dehydrogenase Complex Flavoprotein Subunit A
Bridges the Krebs cycle and electron transport chain (Complex II).
Cytochrome c Oxidase Subunit 4I1
Terminal enzyme of the electron transport chain (Complex IV), driving ATP synthesis.
Why DNA Tells Only Half the Metabolic Story
Your inherited DNA is a static blueprint. It lists genetic variants (SNPs) in genes like PPARG (which regulates adipogenesis) or mitochondrial genes that define your baseline genetic limits. However, DNA never changes; it only shows what might happen.
Transcriptomics (RNA) measures gene expression as it is happening. Because transcription responds to conditions rather than inheritance, a transcript panel reflects the state of these genes at the moment the sample was taken — not a fixed trait.
Protein Panels vs. Transcriptomics
Traditional blood panels measure circulating metabolites and proteins. Transcriptomics measures the gene transcription upstream of them. The two describe different layers of the same biology.
| Protein Marker | What It Measures | RNA Target |
|---|---|---|
| Serum Insulin | Circulating insulin concentration at the time of the draw. | SLC2A4 (GLUT4) |
| Blood Lactate | Circulating lactate concentration, reflecting whole-body glycolytic flux. | AMPK (PRKAA1/2) |
| HbA1c | Reflects mean blood glucose over roughly the preceding 8-12 weeks. | PPARGC1A |
WHAT A TRANSCRIPTIONAL PANEL DOES NOT TELL YOU
- × That you have, or do not have, any medical condition. This panel reports gene activity, not diagnoses.
- × Whether a therapy is working. Transcript levels move for many reasons — sleep, a recent infection, the time of day, how long since you last ate or trained — and a change in them is not evidence that any intervention succeeded or failed.
- × What your results will be next month. Every value describes the moment the sample was drawn. Single-timepoint transcript measurements carry substantial within-person variability.
- × What is happening in a tissue the sample did not come from. These panels run on a blood sample. A blood transcript level is not a muscle, liver, brain or adipose measurement.
From Energy Stress to Respiratory Capacity
Cellular respiration is coordinated by a molecular feedback loop. When cells expend energy, ATP is hydrolysed to ADP, and adenylate kinase converts two ADP into one ATP and one AMP — so AMP rises proportionally much more than ADP does. AMP-Activated Protein Kinase (AMPK) senses that shift (PMID 22436748).
ATP Depletion
Energy consumption hydrolyzes ATP to AMP, shifting intracellular energy ratios.
AMPK Activation
AMPK is switched on by AMP binding plus phosphorylation — not by new transcription — and then drives the catabolic programme whose genes this panel reads (PMID 22436748).
Organelle Expansion
Activated AMPK triggers PGC-1α (PPARGC1A), initiating mitochondrial replication.
OXPHOS Expression
Transcripts for respiratory chain subunits rise, including NDUFS1 (Complex I), SDHA (Complex II) and COX4I1 (Complex IV).
Activating Bioenergetic Transcripts
Each of these has published evidence bearing on bioenergetic signaling. The strength of that evidence differs considerably between them, and is noted on each card.
Intermittent Fasting & Caloric Restriction
Triggers a rapid upregulation in AMPK transcription, shifting cells from nutrient storage to cellular cleanup and metabolic resilience.
Cold Thermogenesis
Activates brown adipose thermogenesis. Note that brown fat transcription is not measurable from a blood sample; this panel reads PPARGC1A in circulating cells only.
Nutritional Cofactors (Berberine & Resveratrol)
Berberine inhibits mitochondrial respiratory complex I, and that is the route by which it activates AMPK (PMID 18285556). Resveratrol is not a direct sirtuin activator — the reported activation turned out to be an artifact of the fluorophore-tagged assay substrate (PMID 20061378).
Zone 2 Cardio Training
Maintains continuous, low-intensity ATP demand, associated with sustained transcription of respiratory chain subunits.
Therapies That Act on These Pathways
These therapies act on genes this panel reports. Biomeme does not prescribe, supply, recommend or evaluate any of them, and listing one here is not a claim that it works. Several are available only by prescription; some are not approved for any use. Where the published evidence is thin or points the other way, the card says so.
Niagen / NR
Dietary supplementRaises NAD+ availability. Human outcome data on mitochondrial respiratory capacity remain limited (PMID 33353981).
NMN
NAD+ is the co-substrate sirtuins consume, so raising NAD+ availability raises sirtuin catalytic activity rather than sirtuin gene transcription (PMID 33353981).
DSIP (delta sleep-inducing peptide)
Not approved for any useStudied for effects on sleep architecture. There are no published human trials of DSIP supporting a bioenergetic effect.
HGH
Prescription onlyPrescription growth hormone, approved only for specific medical conditions. Biomeme makes no claim about its use for any other purpose.
Scientific Citations (4)
- [1] Turner N, Li JY, Gosby A, et al. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008;57(5):1414-1418.
- [2] Pacholec M, Bleasdale JE, Chrunyk B, et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010;285(11):8340-8351.
- [3] Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251-262.
- [4] Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141.
The Biomeme Molecular Ecosystem
From deep whole-transcriptome sequencing in the laboratory to rapid point-of-care instrumentation in the field.
High-Depth RNA Sequencing
Processed at One Health Labs, Biomeme's CLIA-certified laboratory, using Illumina NovaSeq high-depth paired-end RNA sequencing. Samples are collected in venous PAXgene blood RNA tubes to stabilize cellular transcription at the moment of draw.
Biomeme/5 Handheld Platform
Beyond central-lab genomics, Biomeme engineers patented, battery-powered real-time PCR instruments. Our deployable hardware brings decentralized molecular detection directly to the field and clinical points of care.
Curious how we measure this?
Learn about the foundational science of Transcriptomics and how Biomeme brings molecular profiling to the point of need.
Ready to Learn More?
Explore how Biomeme's capabilities are being deployed across the Wellness landscape.
ABOUT THESE PANELS
Biomeme's wellness transcriptomic panels are general wellness products. They report gene activity to support a healthy lifestyle. They are not intended to diagnose, treat, cure, mitigate or prevent any disease or condition, and they are not a substitute for evaluation by a licensed healthcare professional. Results describe the state of the measured transcripts at the moment the sample was taken.